Regulus Therapeutics Inc (NASDAQ:RGLS)

0.649
Delayed Data
As of Apr 23
 -0.0044 / -0.67%
Today’s Change
0.63
Today|||52-Week Range
1.95
-37.60%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.65
Today’s open0.65
Day’s range0.64 - 0.67
Volume187,383
Average volume (3 months)631,518
Market cap$98.6M
Data as of 3:59pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+38.06%
Earnings growth (this year)+42.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-93.97%
P/E ratioNM
Price/Sales1,086.67
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...-0.14-2.27%
GTXIGTX Inc+0.27+1.58%
ZFGNZafgen Inc-0.26-3.80%
MEIPMEI Pharma Inc+0.03+1.40%
Data as of 4:00pm ET, 04/23/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$72.0K
Annual profit (last year)-$71.9M
Net profit margin-99,868.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts